James H. Mackaness, Chief Financial Officer at SOLENO THERAPEUTICS INC (SLNO), sold 15,489 shares at $27.03 ($426K) on 2023-11-28, disclosed to the SEC on 2023-11-30.
Open-market sale of $426k SLNO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.03 | 3,205 | $87K | 20.3% |
| 2 | $27.03 | 3,205 | $87K | 20.3% |
| 3 | $27.59 | 673 | $19K | 4.4% |
| 4 | $27.43 | 2,162 | $59K | 13.9% |
| 5 | $27.43 | 2,162 | $59K | 13.9% |
| 6 | $28.26 | 2,041 |
| $58K |
| 13.5% |
| 7 | $28.26 | 2,041 | $58K | 13.5% |
| Total | $27.49 avg | 15,489 | $426K | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |